🇬🇧 🇫🇷
P

Phaxiam Therapeutics

Biotechnology · France · 200 employees

Biotechnology France B2B Est. 2004
3 Decision makers
200 Employees
2004 Founded

Organizational Chart of Phaxiam Therapeutics

Roles identified within Phaxiam Therapeutics's leadership team, from public professional data, updated 18 Oct 2026.

Phaxiam Therapeutics's Full Organizational Chart

Loading…

Get their contacts on Zeliq →

Job title Department People

Decision makers at Phaxiam Therapeutics by function

General management

See all Phaxiam Therapeutics contacts on Zeliq

Decision makers at Phaxiam Therapeutics

3 identified 1 C-Level 2 VP
See them on Zeliq →

Funding and news at Phaxiam Therapeutics

Funding

Last round Other · $8M
Total funding $196M (12 rounds)
Series A $750K Nov 2005
Venture Round $12M Dec 2006
Series B $5M Jul 2010
Series C $4M Jul 2011
Post-IPO Equity $30M Oct 2014
Post-IPO Equity $25M Dec 2015
Venture Round $70M Apr 2017
Post-IPO Equity N/A Jan 2020
Post-IPO Debt $10M Nov 2020
Post-IPO Equity $30M Apr 2021
Corporate Round N/A Jun 2023
Post-IPO Equity $8M Jun 2024

Team Structure headcount by department

Research
10
Medical
4
Operations
4
Other
4
General Management
3
Finance
2
Technical
2
Education
1

How to prospect Phaxiam Therapeutics's departments
Research

This is where the company's largest headcount sits (10 people). Long cycles and rigorous methods: respect their pace and bring evidence, not hype.

Medical

With 4 people, this is the organisation's second pillar. Medical teams trust peer references: name comparable organisations you already serve.

Operations

4 people work in this department. Process efficiency and cost control are the angles that resonate with these decision makers.

Other

A team of 4 people. Mixed profiles gather here: a discovery-first approach works better than a packaged pitch.

General Management

This department counts 3 people. Executive attention is scarce: one sharp sentence on business impact beats three paragraphs of features.

Try the Zeliq email finder demo →

FAQ Phaxiam Therapeutics

Who runs Phaxiam Therapeutics?

The highest-ranking leadership role identified at Phaxiam Therapeutics is “CEO”, based on public data updated 18 Oct 2026.

How many decision makers does Phaxiam Therapeutics have?

3 decision makers identified, including 1 at executive level.

How do I contact a decision maker at Phaxiam Therapeutics?

Verified emails and phone numbers are available in Zeliq, with free credits at sign-up.

Companies similar to Phaxiam Therapeutics

More companies to explore

Biotechnology · France

All Biotechnology companies in France →

About Phaxiam Therapeutics

Phaxiam Therapeutics operates in the Biotechnology industry, operating from France. The company was founded in 2004 and counts about 200 employees. Phaxiam Therapeutics belongs to the Hospitals and Health Care sector, with a specific positioning on Biotechnology. Phaxiam Therapeutics is a B2B company, primarily serving business clients and professional organisations. Phaxiam Therapeutics has raised funding across 12 rounds totalling $196M. Sales teams can rely on this profile to qualify Phaxiam Therapeutics, spot business signals, and connect with verified decision makers.

Activity & Market

Phaxiam Therapeutics operates in the Biotechnology segment, part of the broader Hospitals and Health Care sector. As a B2B company, Phaxiam Therapeutics primarily serves business clients and professional organisations. The company is categorised as “Public company”.